Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT02974322




Registration number
NCT02974322
Ethics application status
Date submitted
23/11/2016
Date registered
28/11/2016
Date last updated
14/11/2017

Titles & IDs
Public title
A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
Scientific title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
Secondary ID [1] 0 0
GED-0301-CD-003
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Crohn Disease 0 0
Condition category
Condition code
Oral and Gastrointestinal 0 0 0 0
Inflammatory bowel disease
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders
Oral and Gastrointestinal 0 0 0 0
Crohn's disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - GED-0301
Treatment: Drugs - Placebo

Experimental: GED-0301 1 x 160 mg once daily - GED-0301 1 x 160 mg tablet once daily (QD)

Experimental: GED-0301 - 4 x 40 mg once daily - GED-0301 4 x 40 mg tablets once daily (QD)

Placebo Comparator: Placebo once daily - Placebo once daily (QD)


Treatment: Drugs: GED-0301
GED-0301

Treatment: Drugs: Placebo
Placebo
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Clinical remission defined by an average daily liquid or soft stool frequency and abdominal pain score (US) and Crohn's Disease Activity Index (CDAI) (Rest of World)
Timepoint [1] 0 0
week 12
Secondary outcome [1] 0 0
Clinical remission defined by an average daily liquid or soft stool frequency and abdominal pain score (US) and CDAI
Timepoint [1] 0 0
Week 4, week 12
Secondary outcome [2] 0 0
Endoscopic improvement by the Simple Endoscopic Score for Crohn's Disease (SES-CD)
Timepoint [2] 0 0
Week 12
Secondary outcome [3] 0 0
Clinical response defined by CDAI
Timepoint [3] 0 0
Week 4, week 12
Secondary outcome [4] 0 0
Clinical remission defined by PCDAI
Timepoint [4] 0 0
Week 12
Secondary outcome [5] 0 0
Adverse Events (AEs)
Timepoint [5] 0 0
Up to 20 weeks
Secondary outcome [6] 0 0
Pharmacokinetics (PK)- plasma concentration of GED-0301
Timepoint [6] 0 0
Week 4, week 8

Eligibility
Key inclusion criteria
Subjects must satisfy the following criteria to be enrolled in the study:

- Male or female = 12 years

- Subject is able to swallow the IP tablets

- Active Crohn's disease (CD) disease as determined by the Crohn's Disease Activity
Index (CDAI) score and the Simple Endoscopic Score for Crohn's Disease (SES-CD)

- Must meet a determined average minimum number of daily stools or rating of abdominal
pain over a 7day period

- Subject must have failed or experienced intolerance to at least one of the following:
budesonide; systemic corticosteroids; immunosuppressants (eg, azathiopurine,
6-mercaptopurine, or methotrexate); or biologics for the treatment of CD (ie,
infliximab, adalimumab, certolizumab, or vedolizumab).
Minimum age
12 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
• The presence of any of the following will exclude a subject from enrollment: Diagnosis of
ulcerative colitis (UC), indeterminate colitis, ischemic colitis, microscopic colitis,
radiation colitis or diverticular disease-associated colitis, or colitis due to
immunodeficiency

- Local manifestations of Crohn's Disease (CD) such as abscesses, short bowel syndrome;
or other disease complications for which surgery might be indicated or could confound
the evaluation of efficacy

- Subject has strictures with prestenotic dilatation, requiring procedural intervention,
or with obstructive symptoms. In addition, subjects with colonic strictures that are
not passable with an age-appropriate colonoscope, or strictures in the ileum or
ileocecal valve that are fibrotic in nature, will be excluded

- Intestinal resection within 6 months or any intra-abdominal surgery within 3 months
prior to the Screening Visit

- Ileostomy or a colostomy

- Subject has a history of any clinically significant medical condition that, in the
investigator's opinion, would prevent the subject from participating in the study

- Adolescents with delayed growth or pubertal development who are on corticosteroids at
baseline and who should not continue treatment with the same dose of corticosteroids
until the Week 12 visit.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Withdrawn
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
1/12/2017
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
24/12/2018
Actual
Sample size
Target
Accrual to date
Final
0
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Recruitment hospital [1] 0 0
Royal Prince Alfred Hospital - Camperdown
Recruitment hospital [2] 0 0
Concord Repatriation General Hospital - Concord
Recruitment hospital [3] 0 0
Centre For Digestive Diseases - Five Dock
Recruitment hospital [4] 0 0
Liverpool Hospital - Liverpool
Recruitment hospital [5] 0 0
Royal Brisbane and Women's Hospital - Herston
Recruitment hospital [6] 0 0
Mater Adult Hospital - South Brisbane
Recruitment hospital [7] 0 0
Princess Alexandra Hospital - Woolloongabba
Recruitment hospital [8] 0 0
Royal Adelaide Hospital Institute of Medical and Veterinary Science - Adelaide
Recruitment hospital [9] 0 0
Box Hill Hospital - Box Hill
Recruitment hospital [10] 0 0
The Alfred Hospital - Melbourne
Recruitment hospital [11] 0 0
Fiona Stanley Hospital - Murdoch
Recruitment hospital [12] 0 0
Ballarat Base Hospital - Ballarat
Recruitment hospital [13] 0 0
Monash Medical Centre Clayton - Bentleigh East
Recruitment hospital [14] 0 0
St Vincents Hospital Melbourne - Fitzroy
Recruitment postcode(s) [1] 0 0
2050 - Camperdown
Recruitment postcode(s) [2] 0 0
2139 - Concord
Recruitment postcode(s) [3] 0 0
2046 - Five Dock
Recruitment postcode(s) [4] 0 0
2170 - Liverpool
Recruitment postcode(s) [5] 0 0
4029 - Herston
Recruitment postcode(s) [6] 0 0
4101 - South Brisbane
Recruitment postcode(s) [7] 0 0
4102 - Woolloongabba
Recruitment postcode(s) [8] 0 0
5000 - Adelaide
Recruitment postcode(s) [9] 0 0
3128 - Box Hill
Recruitment postcode(s) [10] 0 0
3004 - Melbourne
Recruitment postcode(s) [11] 0 0
6150 - Murdoch
Recruitment postcode(s) [12] 0 0
3350 - Ballarat
Recruitment postcode(s) [13] 0 0
3165 - Bentleigh East
Recruitment postcode(s) [14] 0 0
3065 - Fitzroy
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Arizona
Country [2] 0 0
United States of America
State/province [2] 0 0
Arkansas
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Connecticut
Country [6] 0 0
United States of America
State/province [6] 0 0
Florida
Country [7] 0 0
United States of America
State/province [7] 0 0
Georgia
Country [8] 0 0
United States of America
State/province [8] 0 0
Illinois
Country [9] 0 0
United States of America
State/province [9] 0 0
Indiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Iowa
Country [11] 0 0
United States of America
State/province [11] 0 0
Kansas
Country [12] 0 0
United States of America
State/province [12] 0 0
Kentucky
Country [13] 0 0
United States of America
State/province [13] 0 0
Louisiana
Country [14] 0 0
United States of America
State/province [14] 0 0
Maryland
Country [15] 0 0
United States of America
State/province [15] 0 0
Massachusetts
Country [16] 0 0
United States of America
State/province [16] 0 0
Michigan
Country [17] 0 0
United States of America
State/province [17] 0 0
Minnesota
Country [18] 0 0
United States of America
State/province [18] 0 0
Missouri
Country [19] 0 0
United States of America
State/province [19] 0 0
New Hampshire
Country [20] 0 0
United States of America
State/province [20] 0 0
New Jersey
Country [21] 0 0
United States of America
State/province [21] 0 0
New York
Country [22] 0 0
United States of America
State/province [22] 0 0
North Carolina
Country [23] 0 0
United States of America
State/province [23] 0 0
Ohio
Country [24] 0 0
United States of America
State/province [24] 0 0
Oklahoma
Country [25] 0 0
United States of America
State/province [25] 0 0
Oregon
Country [26] 0 0
United States of America
State/province [26] 0 0
Pennsylvania
Country [27] 0 0
United States of America
State/province [27] 0 0
Rhode Island
Country [28] 0 0
United States of America
State/province [28] 0 0
South Carolina
Country [29] 0 0
United States of America
State/province [29] 0 0
Tennessee
Country [30] 0 0
United States of America
State/province [30] 0 0
Texas
Country [31] 0 0
United States of America
State/province [31] 0 0
Utah
Country [32] 0 0
United States of America
State/province [32] 0 0
Virginia
Country [33] 0 0
United States of America
State/province [33] 0 0
Washington
Country [34] 0 0
United States of America
State/province [34] 0 0
Wisconsin
Country [35] 0 0
Austria
State/province [35] 0 0
Klagenfurt
Country [36] 0 0
Austria
State/province [36] 0 0
Salzburg
Country [37] 0 0
Austria
State/province [37] 0 0
Wein
Country [38] 0 0
Belgium
State/province [38] 0 0
Brussels
Country [39] 0 0
Belgium
State/province [39] 0 0
Edegem
Country [40] 0 0
Belgium
State/province [40] 0 0
Gent
Country [41] 0 0
Belgium
State/province [41] 0 0
Liege
Country [42] 0 0
Canada
State/province [42] 0 0
Alberta
Country [43] 0 0
Canada
State/province [43] 0 0
British Columbia
Country [44] 0 0
Canada
State/province [44] 0 0
Ontario
Country [45] 0 0
Canada
State/province [45] 0 0
Quebec
Country [46] 0 0
Canada
State/province [46] 0 0
Saskatchewan
Country [47] 0 0
Croatia
State/province [47] 0 0
Osijek
Country [48] 0 0
Czechia
State/province [48] 0 0
Hradec Králové
Country [49] 0 0
Czechia
State/province [49] 0 0
Olomouc
Country [50] 0 0
Czechia
State/province [50] 0 0
Praha 3
Country [51] 0 0
Czechia
State/province [51] 0 0
Praha 4
Country [52] 0 0
Denmark
State/province [52] 0 0
Aahus C
Country [53] 0 0
Denmark
State/province [53] 0 0
Alborg
Country [54] 0 0
Denmark
State/province [54] 0 0
Hvidovre
Country [55] 0 0
Denmark
State/province [55] 0 0
Koge
Country [56] 0 0
Denmark
State/province [56] 0 0
Odense C
Country [57] 0 0
Denmark
State/province [57] 0 0
Silkeborg
Country [58] 0 0
Finland
State/province [58] 0 0
Helsinki
Country [59] 0 0
Finland
State/province [59] 0 0
Tampere
Country [60] 0 0
France
State/province [60] 0 0
Amiens Cedex
Country [61] 0 0
France
State/province [61] 0 0
Besancon Cedex
Country [62] 0 0
France
State/province [62] 0 0
Lille cedex
Country [63] 0 0
France
State/province [63] 0 0
Marseille cedex 20
Country [64] 0 0
France
State/province [64] 0 0
Nice Cedex 3
Country [65] 0 0
France
State/province [65] 0 0
Paris Cedex 10
Country [66] 0 0
France
State/province [66] 0 0
Pierre Benite cedex
Country [67] 0 0
France
State/province [67] 0 0
Reims
Country [68] 0 0
France
State/province [68] 0 0
Rouen
Country [69] 0 0
France
State/province [69] 0 0
Toulouse Cedex 09
Country [70] 0 0
France
State/province [70] 0 0
Vandoeuvre les Nancy
Country [71] 0 0
Germany
State/province [71] 0 0
Berlin
Country [72] 0 0
Germany
State/province [72] 0 0
Bochum
Country [73] 0 0
Germany
State/province [73] 0 0
Brandenburg an der Havel
Country [74] 0 0
Germany
State/province [74] 0 0
Dresden
Country [75] 0 0
Germany
State/province [75] 0 0
Erlangen
Country [76] 0 0
Germany
State/province [76] 0 0
Essen
Country [77] 0 0
Germany
State/province [77] 0 0
Frankfurt
Country [78] 0 0
Germany
State/province [78] 0 0
Hamburg
Country [79] 0 0
Germany
State/province [79] 0 0
Kiel
Country [80] 0 0
Germany
State/province [80] 0 0
Leipzig
Country [81] 0 0
Germany
State/province [81] 0 0
Minden
Country [82] 0 0
Germany
State/province [82] 0 0
Regensburg
Country [83] 0 0
Germany
State/province [83] 0 0
Ulm
Country [84] 0 0
Germany
State/province [84] 0 0
Wuppertal
Country [85] 0 0
Greece
State/province [85] 0 0
Athens
Country [86] 0 0
Greece
State/province [86] 0 0
Rio Patras
Country [87] 0 0
Hungary
State/province [87] 0 0
Budapest
Country [88] 0 0
Hungary
State/province [88] 0 0
Szeged
Country [89] 0 0
Israel
State/province [89] 0 0
Petah Tikva
Country [90] 0 0
Israel
State/province [90] 0 0
Rechovot
Country [91] 0 0
Israel
State/province [91] 0 0
Zerifin
Country [92] 0 0
Italy
State/province [92] 0 0
Bologna
Country [93] 0 0
Italy
State/province [93] 0 0
Milano
Country [94] 0 0
Italy
State/province [94] 0 0
Padova
Country [95] 0 0
Italy
State/province [95] 0 0
Palermo
Country [96] 0 0
Italy
State/province [96] 0 0
Pavia
Country [97] 0 0
Italy
State/province [97] 0 0
Pisa
Country [98] 0 0
Italy
State/province [98] 0 0
Roma
Country [99] 0 0
Italy
State/province [99] 0 0
Rome
Country [100] 0 0
Italy
State/province [100] 0 0
Salerno
Country [101] 0 0
Italy
State/province [101] 0 0
San Donato Milanese
Country [102] 0 0
Korea, Republic of
State/province [102] 0 0
Busan
Country [103] 0 0
Korea, Republic of
State/province [103] 0 0
Guri-si
Country [104] 0 0
Korea, Republic of
State/province [104] 0 0
Seongnam-si,
Country [105] 0 0
Korea, Republic of
State/province [105] 0 0
Seongnam-si
Country [106] 0 0
Korea, Republic of
State/province [106] 0 0
Seoul
Country [107] 0 0
Korea, Republic of
State/province [107] 0 0
Suwon-si
Country [108] 0 0
Korea, Republic of
State/province [108] 0 0
Wonju-Si
Country [109] 0 0
Latvia
State/province [109] 0 0
Riga
Country [110] 0 0
Netherlands
State/province [110] 0 0
Breda
Country [111] 0 0
Netherlands
State/province [111] 0 0
Rotterdam
Country [112] 0 0
Poland
State/province [112] 0 0
Bialystok
Country [113] 0 0
Poland
State/province [113] 0 0
Bydgoszcz
Country [114] 0 0
Poland
State/province [114] 0 0
Kraków
Country [115] 0 0
Poland
State/province [115] 0 0
Lodz
Country [116] 0 0
Poland
State/province [116] 0 0
Warsaw
Country [117] 0 0
Poland
State/province [117] 0 0
Wroclaw
Country [118] 0 0
Portugal
State/province [118] 0 0
Braga
Country [119] 0 0
Portugal
State/province [119] 0 0
Guimaraes
Country [120] 0 0
Portugal
State/province [120] 0 0
Lisboa
Country [121] 0 0
Portugal
State/province [121] 0 0
Porto
Country [122] 0 0
Portugal
State/province [122] 0 0
Viana do Castelo
Country [123] 0 0
Romania
State/province [123] 0 0
Oradea
Country [124] 0 0
Romania
State/province [124] 0 0
Timisoara
Country [125] 0 0
Russian Federation
State/province [125] 0 0
Moscow
Country [126] 0 0
Russian Federation
State/province [126] 0 0
Novosibirsk
Country [127] 0 0
Russian Federation
State/province [127] 0 0
Saint-Petersburg
Country [128] 0 0
Russian Federation
State/province [128] 0 0
Samara
Country [129] 0 0
Serbia
State/province [129] 0 0
Belgrade
Country [130] 0 0
Slovakia
State/province [130] 0 0
Presov
Country [131] 0 0
Spain
State/province [131] 0 0
Alicante
Country [132] 0 0
Spain
State/province [132] 0 0
Barcelona
Country [133] 0 0
Spain
State/province [133] 0 0
Madrid
Country [134] 0 0
Spain
State/province [134] 0 0
Pontevedra
Country [135] 0 0
Spain
State/province [135] 0 0
Zaragoza
Country [136] 0 0
Sweden
State/province [136] 0 0
Stockholm
Country [137] 0 0
Switzerland
State/province [137] 0 0
Bern
Country [138] 0 0
Switzerland
State/province [138] 0 0
Geneva
Country [139] 0 0
Switzerland
State/province [139] 0 0
Zuerich
Country [140] 0 0
Turkey
State/province [140] 0 0
Ankara
Country [141] 0 0
Turkey
State/province [141] 0 0
Elazig
Country [142] 0 0
Turkey
State/province [142] 0 0
Istanbul
Country [143] 0 0
Turkey
State/province [143] 0 0
Izmir
Country [144] 0 0
Turkey
State/province [144] 0 0
Kocaeli
Country [145] 0 0
Turkey
State/province [145] 0 0
Malatya
Country [146] 0 0
Turkey
State/province [146] 0 0
Mersin
Country [147] 0 0
Ukraine
State/province [147] 0 0
Kharkiv
Country [148] 0 0
Ukraine
State/province [148] 0 0
Kirovohrad
Country [149] 0 0
Ukraine
State/province [149] 0 0
Kyiv
Country [150] 0 0
Ukraine
State/province [150] 0 0
Odessa
Country [151] 0 0
Ukraine
State/province [151] 0 0
Sumy
Country [152] 0 0
Ukraine
State/province [152] 0 0
Ternopil
Country [153] 0 0
Ukraine
State/province [153] 0 0
Vinnytsia
Country [154] 0 0
Ukraine
State/province [154] 0 0
Zaporizhia
Country [155] 0 0
Ukraine
State/province [155] 0 0
Zaporozhje
Country [156] 0 0
United Kingdom
State/province [156] 0 0
Basingstoke
Country [157] 0 0
United Kingdom
State/province [157] 0 0
Coventry
Country [158] 0 0
United Kingdom
State/province [158] 0 0
Glasgow
Country [159] 0 0
United Kingdom
State/province [159] 0 0
Hull
Country [160] 0 0
United Kingdom
State/province [160] 0 0
London
Country [161] 0 0
United Kingdom
State/province [161] 0 0
Manchester
Country [162] 0 0
United Kingdom
State/province [162] 0 0
Nottingham
Country [163] 0 0
United Kingdom
State/province [163] 0 0
Roxburghshire

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Celgene
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of study is to test the effect of an experimental medication GED-0301(mongersen)
and evaluate its safety in patients (= 12 years of age) with active Crohn's disease. The
study will test GED-0301 compare to placebo for 12 weeks. The study treatment is blinded
which means that patients and the study doctor will not know which treatment has been
assigned. Patients in this study will be allowed treatment with stable doses of oral
aminosalicylates, oral corticosteroids, immunosupressants and antibiotics for the treatment
of Crohn's disease. Adolescent patients will also be allowed treatment with stable doses of
exclusive enteral nutrition and growth hormone.

All patients who complete the study will have the option to enter a long term active
treatment study.
Trial website
https://clinicaltrials.gov/ct2/show/NCT02974322
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Denesh Chitkara, MD
Address 0 0
Celgene Corporation
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT02974322